Skip to content
Disclosery

Robinson Chandler

Reporting owner on Forms 3, 4 and 5, CIK 1727334.

Robinson Chandler reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-02.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Monopar Therapeutics CIK 1645469director, officer (Chief Executive Officer)22026-10-02

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Monopar Therapeutics Common Stock2026-09-30M exercised+9,801109,068Form 4
Monopar Therapeutics Common Stock2026-09-30F withheld for tax-4,344$79.67104,724Form 4
Monopar Therapeutics Common Stock, holding 62,815Form 4
Monopar Therapeutics Restricted Stock Unit, derivative2026-09-30M exercised-9,801$083,602Form 4
Monopar Therapeutics Common Stock2026-09-24M exercised+14,056$30113,323Form 4
Monopar Therapeutics Common Stock2026-09-24M exercised+15,000$14128,323Form 4
Monopar Therapeutics Common Stock2026-09-24S sold-10,450$87.15117,873Form 4
Monopar Therapeutics Common Stock2026-09-24S sold-9,638$87.96108,235Form 4
Monopar Therapeutics Common Stock2026-09-24S sold-8,368$88.9799,867Form 4
Monopar Therapeutics Common Stock2026-09-24S sold-600$89.7999,267Form 4
Monopar Therapeutics Common Stock, holding 62,815Form 4
Monopar Therapeutics Stock Option, derivative2026-09-24M exercised-14,056$015,044Form 4
Monopar Therapeutics Stock Option, derivative2026-09-24M exercised-15,000$027,204Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001437749-26-031925 Monopar Therapeutics2026-10-02
Form 4 0001437749-26-031411 Monopar Therapeutics2026-09-28